# Syntis Bio, Inc.: funding, H-1B, NIH (November 2026)

Registers read on November 19, 2026.

Syntis Bio, Inc. (Massachusetts) appears in 3 public registers SpecStream reads: 4 Form D filings, 3 certified H-1B and PERM cases and 5 NIH and NSF awards; the newest record is dated March 13, 2026, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 3
- Newest record: March 13, 2026
- State: Massachusetts

## Form D filings (SEC)

4 Form D filings, newest July 2, 2025.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/syntis-bio-inc-1943061) | July 2, 2025 | $25 million sold of $26.5 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1943061/000194306125000005/0001943061-25-000005-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/syntis-bio-inc-1943061) | January 27, 2025 | $6.3 million sold of $9 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1943061/000194306125000001/0001943061-25-000001-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/syntis-bio-inc-1943061) | January 17, 2023 | $15.4 million sold of $15.4 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1943061/000194306123000001/0001943061-23-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/syntis-bio-inc-1943061) | August 17, 2022 | $11.2 million sold of $11.2 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1943061/000194306122000003/0001943061-22-000003-index.htm) |

- [SYNTIS BIO, INC.](https://specstream.ai/data/form-d/company/syntis-bio-inc-1943061)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1943061&type=D)

## H-1B and PERM certifications (Department of Labor)

3 certified H-1B and PERM cases, newest March 13, 2026.

- EIN: 88-0608856

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Scientist I \[00102841\]](https://specstream.ai/data/hiring/employer/syntis-bio-inc-880608856) | March 13, 2026 | H-1B, 1 case, $110 thousand offered | [dol.gov](https://www.dol.gov/media/LCA_Disclosure_Data_FY2026_Q2.xlsx) |
| [Research Associate II \[00084981\]](https://specstream.ai/data/hiring/employer/syntis-bio-inc-880608856) | June 3, 2025 | H-1B, 1 case, $79.1 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2025_Q3.xlsx) |
| [Scientist II](https://specstream.ai/data/hiring/employer/syntis-bio-inc-880608856) | January 4, 2023 | H-1B, 1 case, $130 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2023_Q2.xlsx) |

- [Syntis Bio, Inc.](https://specstream.ai/data/hiring/employer/syntis-bio-inc-880608856)

## NIH and NSF research awards

5 NIH and NSF awards, newest September 17, 2025.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [NIH](https://specstream.ai/data/research-funding/organization/syntis-bio-inc-ng1vdvgbhc87) | September 17, 2025 | Development of an Oral Methionine-Gamma-Lyase Enzyme for the Treatment of Homocystinuria; $347 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/11253870) |
| [NIH](https://specstream.ai/data/research-funding/organization/syntis-bio-inc-ng1vdvgbhc87) | September 10, 2025 | Development of Once-daily Oral Treatment for Maple Syrup Urine Disease; $343.6 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/11180795) |
| [NIH](https://specstream.ai/data/research-funding/organization/syntis-bio-inc-ng1vdvgbhc87) | August 1, 2025 | Oral Therapeutics Platform for Treating Inborn Errors of Amino Acid Metabolism; $325 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/11065227) |
| [NIH](https://specstream.ai/data/research-funding/organization/syntis-bio-inc-ng1vdvgbhc87) | September 15, 2024 | Development of an Oral Pill to Mimic the Effects of Gastric Bypass Surgery; $1.2 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/11249883) |
| [NIH](https://specstream.ai/data/research-funding/organization/syntis-bio-inc-ng1vdvgbhc87) | May 1, 2024 | Polymer Epithelial Lining for the Oral Delivery of Macromolecules; $1.6 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/11259211) |

- [Syntis Bio INC](https://specstream.ai/data/research-funding/organization/syntis-bio-inc-ng1vdvgbhc87)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (Massachusetts), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Massachusetts

- [Biotechnology companies in Massachusetts, United States](https://specstream.ai/data/businesses/biotechnology-companies/massachusetts-united-states)
- [Office supply stores in Massachusetts, United States](https://specstream.ai/data/businesses/office-supply-stores/massachusetts-united-states)
- [Coffee shops in Massachusetts, United States](https://specstream.ai/data/businesses/coffee-shops/massachusetts-united-states)
- [Private investigators in Massachusetts, United States](https://specstream.ai/data/businesses/private-investigators/massachusetts-united-states)
- [Dumpster rental companies in Massachusetts, United States](https://specstream.ai/data/businesses/dumpster-rental-companies/massachusetts-united-states)
- [Shipping and delivery companies in Massachusetts, United States](https://specstream.ai/data/businesses/shipping-and-delivery-companies/massachusetts-united-states)
